A Long-term Cost-Effectiveness Analysis of Treatments for Type 2 Diabetes in Portugal: Once-Weekly Semaglutide 1 mg Versus Once-Daily Empagliflozin 25 mg

Authors

Davide Carvalho, Catarina Costa, Nino Hallén, James Baker-Knight, Barnaby Hunt